Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

3.020 +0.050 (+1.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Chamath Palihapitiya Asks If He Should Launch Another SPAC—70% Say No, Users Warn of Past Failures: 'No Crying In The Casino!'
Venture capitalist Chamath Palihapitiya sparked debate on social media by polling followers about launching another Special Purpose Acquisition Company, with 70.7% of 55,458 respondents voting "no"... 
Via Benzinga
1 Unprofitable Stock with Exciting Potential and 2 to Think Twice About
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
3 Volatile Stocks Facing Headwinds
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
Topics Government
Exposures Political
3 Stocks Under $10 in the Doghouse
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
Earnings Scheduled For May 6, 2025
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
(CLOV) - Analyzing Clover Health Investments's Short Interest
Via Benzinga
CLOV Q1 Earnings Call: Membership Growth and Technology Drive Profitability Above Expectations
Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 33.3% year on year to $462.3 million. Its non-GAAP profit of $0.05 per share... 
Via StockStory
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 of Wall Street’s Favorite Stocks Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Clover Health (CLOV) Stock Soars This Week On Q1 Profitability, Up 320% Over Past Year
Shares of Clover Health have surged 8.7% this week. The company reported Q1 results that highlighted rising profitability. 
Via Benzinga
Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2
Via Benzinga
Clover Health Shares Surge After Strong Q1 Earnings, Now Up 409% Over Past Year
Clover Health Investments saw its shares jump more than 12% on Wednesday. Following better-than-expected profitability in the first-quarter, despite missing revenue estimates. 
Via Benzinga
Clover Health (CLOV) Shares Skyrocket, What You Need To Know
Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 13.6% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts' EPS... 
Via StockStory
Topics Initial Public Offering
Exposures Securities Market
Clover Health (NASDAQ:CLOV) Misses Q1 Sales Targets
Health insurance company Clover Health (NASDAQ:CLOV) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 33.3% year on year to $462.3 million. Its GAAP loss of $0 per share was... 
Via StockStory
Clover Health (CLOV) Q1 Earnings: What To Expect
Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow after market hours. Here’s what to look for. 
Via StockStory
3 Cash-Heavy Stocks Skating on Thin Ice
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Topics Supply Chain
Exposures Supply Chain
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
3 Reasons CLOV is Risky and 1 Stock to Buy Instead
Even during a down period for the markets, Clover Health has gone against the grain, climbing to $3.82. Its shares have yielded a 26.1% return over the last six months, beating the S&P 500 by 27.7%.... 
Via StockStory
Topics Stocks
Exposures US Equities
Q4 Earnings Outperformers: Clover Health (NASDAQ:CLOV) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
Unpacking Q4 Earnings: Centene (NYSE:CNC) In The Context Of Other Health Insurance Providers Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Centene (NYSE:CNC) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
MarketBeat Week in Review – 03/03 - 03/07
Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Missed the Hims & Hers Rally? Clover Health Could Be Next
After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space. 
Via MarketBeat
Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?
Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA) 
Via Benzinga
Clover Health (NASDAQ:CLOV) Reports Sales Below Analyst Estimates In Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was... 
Via StockStory
Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday?
The S&P 500 and Nasdaq both slipped into the red, reversing early gains on Thursday, while the Dow Jones remained in positive territory in midday trading. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
What To Expect From Clover Health’s (CLOV) Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.
Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in. 
Via Benzinga
Topics Stocks
Exposures US Equities
Ten Young Ones
Here are a variety of lesser-known charts from my “Recents” watch list. Quite a few of them look like good bullish plays. 
Via Talk Markets
Topics Stocks / Equities
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.